MeiraGTx Holdings PLC (MGTX) - Total Assets
Based on the latest financial reports, MeiraGTx Holdings PLC (MGTX) holds total assets worth $396.45 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MeiraGTx Holdings PLC - Total Assets Trend (2016–2025)
This chart illustrates how MeiraGTx Holdings PLC's total assets have evolved over time, based on quarterly financial data. Also see MeiraGTx Holdings PLC (MGTX) market capitalisation for the company's overall valuation and market capitalisation.
MeiraGTx Holdings PLC - Asset Composition Analysis
Current Asset Composition (December 2025)
MeiraGTx Holdings PLC's total assets of $396.45 Million consist of 37.5% current assets and 62.5% non-current assets. Review debt load of MeiraGTx Holdings PLC to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 27.0% |
| Accounts Receivable | $18.29 Million | 7.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $578.00K | 0.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how MeiraGTx Holdings PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See MGTX live share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MeiraGTx Holdings PLC's current assets represent 37.5% of total assets in 2025, a decrease from 84.7% in 2016.
- Cash Position: Cash and equivalents constituted 27.0% of total assets in 2025, down from 77.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 7.5% of total assets.
MeiraGTx Holdings PLC Competitors by Total Assets
Key competitors of MeiraGTx Holdings PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ALK-Abelló A/S
CO:ALK-B
|
Denmark | Dkr9.17 Billion |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
USA | $890.92 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF3.09 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Nanobiotix
NASDAQ:NBTX
|
USA | $67.76 Million |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
USA | $183.97 Million |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
MeiraGTx Holdings PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.76 | 0.88 | 2.97 |
| Quick Ratio | 3.76 | 0.88 | 2.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $160.25 Million | $-6.35 Million | $117.30 Million |
MeiraGTx Holdings PLC - Advanced Valuation Insights
This section examines the relationship between MeiraGTx Holdings PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.02 |
| Latest Market Cap to Assets Ratio | 5.13 |
| Asset Growth Rate (YoY) | -9.4% |
| Total Assets | $244.43 Million |
| Market Capitalization | $1.25 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values MeiraGTx Holdings PLC's assets at a significant premium (5.13x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: MeiraGTx Holdings PLC's assets decreased by 9.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MeiraGTx Holdings PLC (2016–2025)
The table below shows the annual total assets of MeiraGTx Holdings PLC from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $244.43 Million | -9.39% |
| 2024-12-31 | $269.75 Million | -17.44% |
| 2023-12-31 | $326.74 Million | +2.67% |
| 2022-12-31 | $318.24 Million | -0.60% |
| 2021-12-31 | $320.16 Million | -11.97% |
| 2020-12-31 | $363.70 Million | +12.29% |
| 2019-12-31 | $323.89 Million | +234.27% |
| 2018-12-31 | $96.89 Million | +274.77% |
| 2017-12-31 | $25.85 Million | +14.65% |
| 2016-12-31 | $22.55 Million | -- |
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also develops AAV-AQP1 for radiation-induced grade 2/3 radiation-induced xe… Read more